Risk factors for monoclonal gammopathy of undetermined significance: a systematic review

被引:21
作者
Castaneda-Avila, Maira A. [1 ]
Ulbricht, Christine M. [1 ]
Epstein, Mara Meyer [1 ,2 ,3 ]
机构
[1] Univ Massachusetts, Sch Med, Dept Populat & Quantitat Hlth Sci, Worcester, MA USA
[2] Univ Massachusetts, Sch Med, Meyers Primary Care Inst, 365 Plantat St,Suite 100, Worcester, MA 01605 USA
[3] Univ Massachusetts, Sch Med, Dept Med, 365 Plantat St,Suite 100, Worcester, MA 01605 USA
基金
美国国家卫生研究院;
关键词
MGUS; Risk factors; Systematic review; PRECEDES MULTIPLE-MYELOMA; SIGNIFICANCE MGUS; PRIOR AUTOIMMUNE; POOLED ANALYSIS; PREVALENCE; OBESITY; MORTALITY; CANCER; WHITE; METAANALYSIS;
D O I
10.1007/s00277-021-04400-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monoclonal gammopathy of undetermined significance (MGUS), precursor of multiple myeloma, is an asymptomatic plasma cell disorder that overproduces serum monoclonal protein. Older age, male sex, black race, and family history of MGUS increase the risk of MGUS, yet other risk factors are known. We systematically reviewed observational epidemiological studies that examined sociodemographic, clinical, and behavioral risk factors for the development of MGUS. The protocol for this study was registered on the PROSPERO registry for systematic reviews. We identified epidemiological studies from PubMed and Scopus. Articles were limited to those written in English and published before February 2019. Five case-control and three cohort studies were eligible for data extraction. Studies evaluating factors associated with MGUS risk are limited, with conflicting conclusions regarding risk associated with obesity. Despite the limited research, a significant elevated risk for being diagnosed with MGUS was associated with several specific prior infections, inflammatory disorders, and smoking. The sparse existing literature suggests an increased risk of MGUS associated with several risk factors related to immune function. Further research is needed to explore the potential mechanisms underlying the development of MGUS and to confirm risk factors, both modifiable and non-modifiable.
引用
收藏
页码:855 / 863
页数:9
相关论文
共 50 条
  • [1] Risk factors for monoclonal gammopathy of undetermined significance: a systematic review
    Maira A. Castaneda-Avila
    Christine M. Ulbricht
    Mara Meyer Epstein
    Annals of Hematology, 2021, 100 : 855 - 863
  • [2] Overweight/Obesity and Monoclonal Gammopathy of Undetermined Significance
    Georgakopoulou, Rebecca
    Andrikopoulou, Angeliki
    Sergentanis, Theodoros N.
    Fiste, Oraianthi
    Zagouri, Flora
    Gavriatopoulou, Maria
    Psaltopoulou, Theodora
    Kastritis, Efstathios
    Terpos, Evangelos
    Dimopoulos, Meletios-Athanasios
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06) : 361 - 367
  • [3] Reappraisal of risk factors for monoclonal gammopathy of undetermined significance
    Boursi, Ben
    Weiss, Brendan M.
    Haynes, Kevin
    Mamtani, Ronac
    Yang, Yu-Xiao
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (06) : 581 - 584
  • [4] Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
    Verma, Karina P.
    Steuer, Rebecca
    Edwards, Camille V.
    HEMATO, 2023, 4 (04): : 331 - 349
  • [5] Prevalence of Monoclonal Gammopathy of Undetermined Significance: A Systematic Review
    Wadhera, Rishi K.
    Rajkumar, S. Vincent
    MAYO CLINIC PROCEEDINGS, 2010, 85 (10) : 933 - 942
  • [6] Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
    Sigurbergsdottir, Adalbjoerg Yr
    Love, Thorvardur Jon
    Kristinsson, Sigurour Yngvi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study
    Thordardottir, Marianna
    Lindqvist, Ebba K.
    Lund, Sigrun H.
    Costello, Rene
    Burton, Debra
    Korde, Neha
    Mailankody, Sham
    Eiriksdottir, Gudny
    Launer, Lenore J.
    Gudnason, Vilmundur
    Harris, Tamara B.
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    BLOOD ADVANCES, 2017, 1 (24) : 2186 - 2192
  • [8] Monoclonal Gammopathy of Undetermined Significance: A Comprehensive Review
    Kaur, Jasneet
    Valisekka, Sai Sudha
    Hameed, Maha
    Bandi, Pushyami Satya
    Varma, Samyukta
    Onwughalu, Chibuzor Joseph
    Ibrahim, Hany
    Mongia, Himani
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (05) : E195 - E212
  • [9] Monoclonal gammopathy of undetermined significance
    Decaux, O.
    REVUE DE MEDECINE INTERNE, 2013, 34 : A2 - A3
  • [10] The significance of monoclonal gammopathy of undetermined significance
    Kyle, Robert A.
    Kumar, Shaji
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (12): : 1641 - 1644